Nicole Eggert Says She Has Breast Cancer, ‘Panics’ Over Spread Uncertainty
The former “Baywatch” and “Charles in Charge” star said she is concerned for her 12-year-old daughter amid the actor’s “rough” journey.
Similar Posts
New antibiotic kills deadly, drug-resistant bacteria in ‘scientific breakthrough’
Read this article for free! Plus get unlimited access to thousands of articles, videos and more with your free account! Please enter a valid email address. By entering your email, you are agreeing to Fox News Terms of Service and Privacy Policy, which includes our Notice of Financial Incentive. To access the content, check your…
Toxic debate over lab leak theory hampers search for Covid origins
US agencies cannot agree on how the pandemic started, with the scientific community bitterly divided.
Narcan, The Lifesaving Drug That Can Reverse An Opioid Overdose, Can Be Bought Over The Counter Soon
The Food and Drug Administration has approved Narcan, a naloxone nasal spray that can reverse opioid overdoses and save lives, for over-the-counter use. In an announcement Wednesday, FDA Commissioner Robert M. Califf said the move is meant to address a “dire public health need” and will help increase access and reduce opioid overdose deaths in…
Creating a Healthier Home: Tips for Toxic-Free Living Spaces
In our pursuit of a healthier lifestyle, we often focus on diet and exercise but overlook the impact of our living environment on our well-being. Many homes contain a surprising array of toxins, from household cleaning products to building materials, which can contribute to a range of health issues. Creating a healthier, toxic-free home is…
New COVID variant JN.1 surges to 44% of cases, CDC estimates — even higher in New York, New Jersey
The new COVID-19 variant that scientists call JN.1 now makes up about 44.1% of COVID-19 cases across the country, the Centers for Disease Control and Prevention estimated Friday, marking another week of the fast-spreading variant’s steep rise in the U.S. The increase is more than two times larger than the 21.3% that the CDC now…
Asia’s year in review: Who had it good — and who had it bad — in 2023
Curtis S. Chin, a former U.S. ambassador to the Asian Development Bank, is managing director of advisory firm RiverPeak Group. Jose B. Collazo is an analyst focusing on the Indo-Pacific region. Follow them on X at @CurtisSChin and @JoseBCollazo. As 2023 comes to a close, we take a look at the year that was in…
